نتائج البحث

Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs-Protocols and Advice for the FDA to Meet the ALS Act Vision.

• Authors : Niazi SK; College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.

Subjects: United States Food and Drug Administration* ; Drug Approval* ; Biological Availability*

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 23; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

New Oncologic Drugs from 2008 to 2023-Differences in Approval and Access between the United States, Europe and Brazil.

• Authors : Barreto RB; Centro de Pesquisa Oncológicas-CEPON, Rodovia Admar Gonzada, 655, Florianópolis 88034-000, SC, Brazil.; Izidoro AM

Subjects: Drug Approval* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Aug 02; Vol. 31 (8), pp. 4443-4454. Date of Electronic Publication: 2024 Aug 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

Artificial Intelligence and Machine Learning in the Diagnosis and Management of Stroke: A Narrative Review of United States Food and Drug Administration-Approved Technologies.

• Authors : Chandrabhatla, Anirudha S.^1,2 (AUTHOR); Kuo, Elyse A.^1,2 (AUTHOR); Sokolowski, Jennifer D.² (AUTHOR)

• Source: Journal of Clinical Medicine. Jun2023, Vol. 12 Issue 11, p3755. 27p.

تفاصيل العنوان

Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database.

• Authors : Zheng, Yi¹ (AUTHOR); Guo, Xiaojing¹ (AUTHOR); Chen, Chenxin¹ (AUTHOR)

• Source: Pharmaceuticals (14248247). Jan2023, Vol. 16 Issue 1, p98. 12p.

تفاصيل العنوان

TATA-Binding Protein-Based Virtual Screening of FDA Drugs Identified New Anti-Giardiasis Agents.

• Authors : Gaona-López C; Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.; Méndez-Álvarez D

Subjects: Giardiasis*/Giardiasis*/Giardiasis*/drug therapy ; Giardia lamblia*/Giardia lamblia*/Giardia lamblia*/drug effects ; Molecular Docking Simulation*

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 05; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Dietary Exposure to United States Food and Drug Administration-Approved Synthetic Food Colors in Children, Pregnant Women, and Women of Childbearing Age Living in the United States.

• Authors : Bradman A; Center for Environmental Research and Community Health (CERCH), School of Public Health, University of California at Berkeley, 1995 University Avenue, Suite 265, Berkeley, CA 94704, USA.; Department of Public Health, School of Social Sciences, Humanities, and Art, University of California at Merced, 5200 N. Lake Road, Merced, CA 95343, USA.

Subjects: Dietary Exposure* ; Pregnant Women*; Adolescent

• Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Aug 05; Vol. 19 (15). Date of Electronic Publication: 2022 Aug 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies.

• Authors : Barghash RF; Institute of Chemical Industries Research, National Research Centre, Dokki, Cairo 12622, Egypt.; Faculty of Biotechnology, October University for Modern Sciences and Arts (MSA), Cairo 12451, Egypt.

Subjects: COVID-19 Drug Treatment* ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology SARS-CoV-2 variants

• Source: Molecules (Basel, Switzerland) [Molecules] 2024 Nov 25; Vol. 29 (23). Date of Electronic Publication: 2024 Nov 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use.

• Authors : Benedetto Tiz D; Group of Catalysis, Synthesis and Organic Green Chemistry, Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06100 Perugia, Italy.; Bagnoli L

Subjects: United States Food and Drug Administration* ; Drug Approval*; United States

• Source: Molecules (Basel, Switzerland) [Molecules] 2022 Mar 02; Vol. 27 (5). Date of Electronic Publication: 2022 Mar 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules.

• Authors : de la Torre BG; KRISP, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.; Albericio F

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/history ; Drug Approval*/Drug Approval*/Drug Approval*/statistics & numerical data ; Drug Industry*/Drug Industry*/Drug Industry*/history

• Source: Molecules (Basel, Switzerland) [Molecules] 2022 Feb 05; Vol. 27 (3). Date of Electronic Publication: 2022 Feb 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Lectin-Based Fluorescent Comparison of Glycan Profile-FDA Validation to Expedite Approval of Biosimilars.

• Authors : Niazi SK; College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.; Omarsdottir S

Subjects: Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/analysis ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/chemistry ; Lectins*/Lectins*/Lectins*/metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 26; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان